95 related articles for article (PubMed ID: 8057685)
1. Effectiveness of fludarabine in end-stage prolymphocytic leukemia.
Doorduijn JK; Michiels JJ
Leukemia; 1994 Aug; 8(8):1439. PubMed ID: 8057685
[No Abstract] [Full Text] [Related]
2. Phenotypic changes of leukemic cells in a patient with prolympho-plasmacytic leukaemia after treatment with fludarabine.
Loria MP; Dell'Osso A; Grande M; Dambra P; D'Oronzio L; Crollo R; Lasaracina E; Lucivero G
Eur J Histochem; 1997; 41 Suppl 2():29-30. PubMed ID: 9859769
[No Abstract] [Full Text] [Related]
3. Sustained response of refractory prolymphocytic leukemia to fludarabine.
Sporn JR
Acta Haematol; 1991; 85(4):209-11. PubMed ID: 1853684
[TBL] [Abstract][Full Text] [Related]
4. Acute tumor lysis syndrome complicating fludarabine treatment of prolymphocytic leukemia.
Cannon LM; Spilove L; Rhodes R; Garfinkel H; Pezzimenti J
Conn Med; 1993 Oct; 57(10):651-4. PubMed ID: 8275684
[TBL] [Abstract][Full Text] [Related]
5. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
Rai KR; Peterson BL; Appelbaum FR; Kolitz J; Elias L; Shepherd L; Hines J; Threatte GA; Larson RA; Cheson BD; Schiffer CA
N Engl J Med; 2000 Dec; 343(24):1750-7. PubMed ID: 11114313
[TBL] [Abstract][Full Text] [Related]
6. Leukemic pleural effusion in B-cell prolymphocytic leukemia.
Andrieu V; Encaoua R; Carbon C; Couvelard A; Grange MJ
Hematol Cell Ther; 1998 Dec; 40(6):275-8. PubMed ID: 9924927
[TBL] [Abstract][Full Text] [Related]
7. Treatment of refractory T-cell chronic lymphocytic leukemia with purine nucleoside analogues.
Witzig TE; Weitz JJ; Lundberg JH; Tefferi A
Leuk Lymphoma; 1994 Jun; 14(1-2):137-9. PubMed ID: 7920220
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemia.
Kantarjian HM; Childs C; O'Brien S; Huh Y; Beran M; Schachner J; Koller C; Keating MJ
Am J Med; 1991 Feb; 90(2):223-8. PubMed ID: 1996592
[TBL] [Abstract][Full Text] [Related]
9. Fludarabine for chronic lymphocytic leukemia.
Erman M; Celik I; Tekuzman G
N Engl J Med; 2001 Apr; 344(15):1166; author reply 1167-8. PubMed ID: 11302142
[No Abstract] [Full Text] [Related]
10. When and how to treat chronic lymphocytic leukemia.
Dighiero G; Binet JL
N Engl J Med; 2000 Dec; 343(24):1799-801. PubMed ID: 11114321
[No Abstract] [Full Text] [Related]
11. Fludarabine-induced cytogenetic remission in prolymphocytic leukemia.
Marlton P; McCarthy C; Taylor K
Am J Hematol; 1992 May; 40(1):71-2. PubMed ID: 1566752
[No Abstract] [Full Text] [Related]
12. Prolonged bone marrow aplasia of refractory prolymphocytoid variant of B-cell chronic lymphocytic leukemia related to fludarabine treatment.
Zinzani PL; Tabanelli M; Bendandi M; Tura S
Eur J Haematol; 1994 Jul; 53(1):56-8. PubMed ID: 8062900
[No Abstract] [Full Text] [Related]
13. [Chronic lymphocytic leukemia. 2. Therapy].
Hallek M; Schmitt B; Emmerich B; Stein H
Dtsch Med Wochenschr; 2001 Jun; 126(23):690-5. PubMed ID: 11441667
[No Abstract] [Full Text] [Related]
14. The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011).
Solh M; Rai KR; Peterson BL; Kolitz JE; Appelbaum FR; Tallman MS; Belch A; Larson RA; Morrison VA
Leuk Lymphoma; 2013 Feb; 54(2):252-4. PubMed ID: 22897733
[TBL] [Abstract][Full Text] [Related]
15. Prolymphocytic leukemia or prolymphocytic transformation of mantle cell lymphoma.
Veillon DM; Nordberg ML; Glass J; Sattar T; Cotelingam JD
Am J Clin Pathol; 2001 Nov; 116(5):781-2. PubMed ID: 11710698
[No Abstract] [Full Text] [Related]
16. Fludarabine for chronic lymphocytic leukemia.
Marchetti M; Barosi G; Liberato LN
N Engl J Med; 2001 Apr; 344(15):1166-7; author reply 1167-8. PubMed ID: 11302140
[No Abstract] [Full Text] [Related]
17. A randomized phase II trial of high-dose chlorambucil vs. fludarabine in patients with advanced B-chronic lymphocytic leukemia. EORTC Leukemia Cooperative Group.
Hematol Cell Ther; 1999 Jun; 41(3):127-36. PubMed ID: 10456443
[No Abstract] [Full Text] [Related]
18. [Remission in T-cell prolymphocytic leukemia during the FMC treatment course].
Valiev TT; Vinogradova IuE; Chernova NG; Mar'in DS; Volkova IaK; Petrova VI; Bulanov AIu; Kalinin NN; Semenova EA; Gretsov EM; Kravchenko SK; Kremenetskaia AM; Vorob'ev AI
Ter Arkh; 2006; 78(7):87-90. PubMed ID: 16944758
[No Abstract] [Full Text] [Related]
19. Conjunctival involvement with T-cell prolymphocytic leukemia: report of a case and review of the literature.
Lee SS; Robinson MR; Morris JC; Mirtsching BC; Shen D; Chan CC
Surv Ophthalmol; 2004; 49(5):525-36. PubMed ID: 15325197
[TBL] [Abstract][Full Text] [Related]
20. Richter syndrome and fludarabine: a controversial relationship.
Rossi D
Leuk Lymphoma; 2013 Feb; 54(2):213-4. PubMed ID: 22897730
[No Abstract] [Full Text] [Related]
[Next] [New Search]
